Richard Whitley
Affiliations: | Hong Kong Polytechnic University (Hong Kong) |
Area:
Management Business AdministrationGoogle:
"Richard Whitley"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Whitley RJ, Hook EW. (2022) Shedding Patterns of Genital Herpes Simplex Virus Infections. Jama. 328: 1710-1711 |
Bernstock JD, Bag A, Fiveash J, et al. (2020) Design and Rationale for First-In-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors. Human Gene Therapy |
Kong M, Zhang WW, Sewell K, et al. (2020) Azithromycin Treatment vs Placebo in Children With Respiratory Syncytial Virus-Induced Respiratory Failure: A Phase 2 Randomized Clinical Trial. Jama Network Open. 3: e203482 |
Acosta E, Bowlin T, Brooks J, et al. (2020) Advances in the Development of Therapeutics for Cytomegalovirus Infections. The Journal of Infectious Diseases. 221: S32-S44 |
Whitley R. (2020) Mark Prichard: Scholar, family man and friend. Antiviral Research. 104715 |
Roosenhoff R, Reed V, Kenwright A, et al. (2019) Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
Whitley RJ. (2019) Congenital Cytomegalovirus and Neonatal Herpes Simplex Virus Infections: To Treat or Not to Treat? The Pediatric Infectious Disease Journal. 38: S60-S63 |
Akhtar LN, Bowen CD, Renner DW, et al. (2019) Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population. Msphere. 4 |
Whitley RJ. (2019) Herpes Simplex Virus in Children. Current Treatment Options in Neurology. 4: 231-237 |
Cassady K, Miller K, Prasad N, et al. (2019) ATIM-32. PREDICTORS OF IMPROVED SURVIVAL FOLLOWING ONCOLYTIC VIRUS TREATMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA: GENE EXPRESSION ANALYSIS FROM THE PHASE IB G207 CLINICAL TRIAL Neuro-Oncology. 21: vi8-vi8 |